Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -166.55 Million SEK | -17.64% |
| 2022 | -141.57 Million SEK | -4.51% |
| 2021 | -135.47 Million SEK | -0.46% |
| 2020 | -134.85 Million SEK | -28.73% |
| 2019 | -104.75 Million SEK | -25.07% |
| 2018 | -85.45 Million SEK | -90.53% |
| 2017 | -43.95 Million SEK | -210.15% |
| 2016 | -14.17 Million SEK | -99.78% |
| 2015 | -7.09 Million SEK | 17.5% |
| 2014 | -8.59 Million SEK | -686.16% |
| 2013 | -1.09 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -22.37 Million SEK | -12425.97% |
| 2024 Q1 | 181 Thousand SEK | 100.36% |
| 2023 Q3 | -35.42 Million SEK | 8.82% |
| 2023 Q4 | -49.71 Million SEK | -40.34% |
| 2023 FY | - SEK | -17.64% |
| 2023 Q1 | -42.57 Million SEK | 29.87% |
| 2023 Q2 | -38.84 Million SEK | 8.76% |
| 2022 Q3 | -16.41 Million SEK | 39.17% |
| 2022 Q2 | -26.97 Million SEK | 28.04% |
| 2022 Q1 | -37.48 Million SEK | 12.73% |
| 2022 FY | - SEK | -4.51% |
| 2022 Q4 | -60.7 Million SEK | -269.93% |
| 2021 Q1 | -20.3 Million SEK | 60.49% |
| 2021 Q3 | -29.56 Million SEK | 30.67% |
| 2021 Q2 | -42.64 Million SEK | -110.0% |
| 2021 FY | - SEK | -0.46% |
| 2021 Q4 | -42.95 Million SEK | -45.28% |
| 2020 Q1 | -24.96 Million SEK | 17.16% |
| 2020 Q2 | -25.9 Million SEK | -3.77% |
| 2020 Q3 | -32.75 Million SEK | -26.45% |
| 2020 Q4 | -51.39 Million SEK | -56.94% |
| 2020 FY | - SEK | -28.73% |
| 2019 Q4 | -30.12 Million SEK | -29.94% |
| 2019 Q1 | -23.99 Million SEK | 4.23% |
| 2019 Q3 | -23.18 Million SEK | 15.47% |
| 2019 Q2 | -27.42 Million SEK | -14.34% |
| 2019 FY | - SEK | -25.07% |
| 2018 Q2 | -25.45 Million SEK | -51.61% |
| 2018 Q1 | -16.79 Million SEK | -12.52% |
| 2018 Q3 | -16.45 Million SEK | 35.34% |
| 2018 Q4 | -25.05 Million SEK | -52.2% |
| 2018 FY | - SEK | -90.53% |
| 2017 Q2 | -10.28 Million SEK | -36.58% |
| 2017 Q3 | -11.21 Million SEK | -9.07% |
| 2017 Q4 | -14.92 Million SEK | -33.0% |
| 2017 FY | - SEK | -210.15% |
| 2017 Q1 | -7.53 Million SEK | -46.79% |
| 2016 Q4 | -5.13 Million SEK | -30.84% |
| 2016 Q3 | -3.92 Million SEK | -40.09% |
| 2016 Q2 | -2.79 Million SEK | -20.54% |
| 2016 Q1 | -2.32 Million SEK | -34.85% |
| 2016 FY | - SEK | -99.78% |
| 2015 Q2 | -1.84 Million SEK | 0.0% |
| 2015 Q3 | -1.72 Million SEK | 6.72% |
| 2015 Q4 | -1.72 Million SEK | 0.0% |
| 2015 FY | - SEK | 17.5% |
| 2015 Q1 | -1.84 Million SEK | 37.44% |
| 2014 Q4 | -2.95 Million SEK | 0.0% |
| 2014 FY | - SEK | -686.16% |
| 2014 Q1 | -1.39 Million SEK | 0.0% |
| 2014 Q2 | -1.39 Million SEK | 0.0% |
| 2014 Q3 | -2.95 Million SEK | -110.86% |
| 2013 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -14221.066% |
| Arrayit Corporation | -3.07 Million USD | -5311.999% |
| Atlantic International Corp. | -5.38 Million USD | -2990.308% |
| Biocept, Inc. | -30.24 Million USD | -450.756% |
| Bioqual, Inc. | 3.03 Million USD | 5592.771% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -21890.956% |
| DermTech, Inc. | -97.89 Million USD | -70.139% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 105.715% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | -722.795% |
| iMD Companies, Inc. | -154.65 Thousand USD | -107591.114% |
| IDenta Corp. | 71.58 Thousand USD | 232759.561% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 4440.735% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 430583.329% |
| InVitro International | 6680.00 USD | 2493423.353% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -2963.907% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -1372522.383% |
| Medical Imaging Corp. | -896.74 Thousand USD | -18473.235% |
| NovelStem International Corp. | -3.78 Million USD | -4299.441% |
| Optigenex Inc. | -1.18 Million USD | -13934.771% |
| PharmChem, Inc. | 1.05 Million USD | 15904.936% |
| Proteome Sciences plc | -1.13 Million USD | -14548.549% |
| Response Genetics, Inc | -19.66 Million USD | -746.913% |
| Rennova Health, Inc. | -234.81 Thousand USD | -70829.881% |
| RushNet, Inc. | -614.85 Thousand USD | -26988.47% |
| ScreenPro Security Inc. | -3.43 Million USD | -4748.89% |
| Stella Diagnostics Inc. | -5.7 Million USD | -2818.196% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -1521.731% |
| Todos Medical Ltd. | -9.39 Million USD | -1672.983% |